SHPG Share Price

Open 162.44 Change Price %
High 163.42 1 Day 1.44 0.89
Low 161.09 1 Week -5.02 -2.99
Close 163.15 1 Month -5.50 -3.26
Volume 922982 1 Year -19.12 -10.49
52 Week High 209.22
52 Week Low 147.60
SHPG Important Levels
Resistance 2 165.31
Resistance 1 164.42
Pivot 162.55
Support 1 161.88
Support 2 160.99
NASDAQ USA Most Active Stocks
ASTI 0.01 0.00%
QCOM 54.88 -12.72%
QCOM 54.88 -12.72%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
More..
NASDAQ USA Top Gainers Stocks
EDMC 0.02 100.00%
CPSL 0.10 66.67%
LOCM 0.09 50.00%
ACFN 0.30 30.43%
LTRE 2.85 29.55%
WRES 0.09 28.57%
QKLS 0.14 27.27%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
QTWW 0.08 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Shire plc (NASDAQ: SHPG)

SHPG Technical Analysis 5
As on 23rd Jan 2017 SHPG Share Price closed @ 163.15 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 180.83 & Strong Sell for SHORT-TERM with Stoploss of 172.36 we also expect STOCK to react on Following IMPORTANT LEVELS.
SHPG Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
Shire plc ( NASDAQ USA Symbol : SHPG )
Sector : N/AIndustry:N/AFull Time Employees:5,338Business Summary Shire plc, a biopharmaceutical company, together with its subsidiaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various And Other Stocks in Same Sector
SHPG
163.15 1.44 (0.89 %)
LT : Strong Sell
ST : Strong Sell
SHPG Other Details
Segment EQ
Market Capital 16032273408.00
Sector N/AIndustry:N/AFull Time Employees:5,338Business Summary Shire plc, a biopharmaceutical company, together with its subsidiaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various
Industry N/AFull Time Employees:5,338Business Summary Shire plc, a biopharmaceutical company, together w
Offical website http://www.shire.com
SHPG Address
SHPG
5 Riverwalk
Citywest Business Campus
Dublin, 24
Ireland
Phone: 353 1 429 7700
Interactive Technical Analysis Chart Shire plc ( SHPG NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Shire plc
SHPG Business Profile
Shire plc (Shire) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), gastrointestinal (GI) diseases, human genetic therapies (HGT) and regenerative medicine (RM), as well as opportunities in other therapeutic areas. On January 31, 2012, the United States Food and Drug Administration approved VYVANSE for the maintenance treatment of ADHD in adults. In March 2013, it announced the acquisition Of Premacure AB. In January 2014, Shire Plc sold its DERMAGRAFT assets to Organogenesis Inc. In January 2014, Shire Plc acquired 79.5% interest in ViroPharma Inc.